Business
CSL (ASX:CSL) share price up after AstraZeneca vaccine approved for use in Australia
The CSL Limited (ASX: CSL) share price is up by 2.73% today. The positive price movement comes on the heels of news the Australian government has approved use of its COVID-19 vaccine within the country.
At the time of writing, shares in the pharmaceutical giant are trading for $260.87 – up 2.44%. By comparison the S&P/ASX 200 Index (ASX: XJO) is up 0.66%.
Let’s take a closer at the government’s announcement.
CSL-made AstraZeneca vaccine will be used in Australia
The CSL share price is responding well to today’s news. The Therapeutic Goods Administration (TGA) announced late on Sunday it had approved use of the…
-
Noosa News24 hours agoMitch Power Quick Shear event gets men talking about mental health
-
Noosa News18 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs
-
Noosa News19 hours agoCreating space for cultural pride – Proctor
-
Noosa News21 hours agoNASAA Certified Organic collapse threatens export capabilities for hundreds of Australian producers